| Literature DB >> 34191172 |
Thapakorn Charoenying1, Prasopchai Patrojanasophon1, Tanasait Ngawhirunpat1, Theerasak Rojanarata1, Prasert Akkaramongkolporn1, Praneet Opanasopit2.
Abstract
This study aimed to optimize the size of capsule-shaped 3D-printed devices (CPD) using an experimental design by the response surface methodology to provide a gastroretentive drug delivery system (GRDDS) with optimal floating time. The CPD was fabricated using a fused deposition modeling (FDM) 3D printer. The central composite design was employed for the optimization of the devices. The morphology of the CPD was observed using a digital microscope and scanning electron microscope (SEM). The in vitro floating time and drug release were evaluated using a USP dissolution apparatus II. Appropriate total floating time (TFT) of the devices (more than 3 h) was obtained with the device's body, cap, and bottom thickness of 1.2, 1.8, and 2.9 mm, respectively. The release kinetics of the drug from the devices fitted well with zero-order kinetics. In conclusion, the optimization of CPD for GRDDS using the experimental design provided the devices with desirable floating time and ideal drug release characteristics.Entities:
Keywords: central composite design; domperidone; experimental design; floating 3D-printed device; fused deposition modeling
Year: 2021 PMID: 34191172 DOI: 10.1208/s12249-021-02053-3
Source DB: PubMed Journal: AAPS PharmSciTech ISSN: 1530-9932 Impact factor: 3.246